Brain tumor revealed by treatment-resistant depression

December 22, 2015, British Medical Journal

A woman who was thought to have treatment-resistant depression was later found to have a tumour in her brain, according to an article published in BMJ Case Reports.

The 54-year-old woman had been depressed for 6 months, but treatment with the antidepressant fluoxetine and the anti-anxiety medication bromazepam was discontinued after 5 months because these were not found to be effective.

Her symptoms included apathy, difficulties with making decisions and initiating action, a lack of energy, sleep disorders, and concentration and attention problems.

She had suicidal thoughts, admitted self-accusation due to ineffectiveness in her job, and lost interest in her usual past times. She did not have a history of personal or familial mental illness, but experienced several .

A neurological examination was normal. However, a CT scan and MRI revealed meningiomatosis with a giant meningioma—the most common primary benign brain tumour—in her left frontal lobe.

This is an area known to have an important role in the development of depression for with tumours in the brain.

The patient underwent emergency surgery, and made a recovery. The disappeared within one month.

Psychiatric symptoms such as depression, mania, hallucinations, anxiety disorders and anorexia nervosa, even without any neurological signs, may be a sign of a brain tumour, write the doctors who treated the patient.

They say that certain patients should have a brain scan to identify or exclude the possibility of a tumour, but note that "it seems unrealistic to prescribe brain imaging in every patient with a depressive syndrome" because this mental disorder is common while are "remarkably rare" in patients with depression.

They recommend that it should be performed if the patient presents a late onset of depressive syndrome after 50 years of age, if a diagnosis of treatment-resistant depression is made or if the patient is apathetic.

Explore further: Certain antidepressants linked to heightened risk of mania and bipolar disorder

More information: Meningiomatosis revealed by a major depressive syndrome, BMJ Case Reports, casereports.bmj.com/content/2015/bcr-2015-211909

Related Stories

Certain antidepressants linked to heightened risk of mania and bipolar disorder

December 15, 2015
Taking certain antidepressants for depression is linked to a heightened risk of subsequent mania and bipolar disorder, reveals research published in the online journal BMJ Open.

Brain tumor patients should be screened for depression

April 29, 2015
Because depression in brain cancer patients is a common but often overlooked condition, oncologists should regularly screen tumor patients for depression, according to an article in the current issue of CNS Oncology.

Depression too often reduced to a checklist of symptoms

October 23, 2015
How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM) - the 'bible' of psychiatry - diagnoses depression when patients tick off a certain number of symptoms on the DSM checklist. ...

First mouse model of spontaneous depression-like episodes shows new candidate brain region

October 20, 2015
Scientists from the RIKEN Brain Science Institute have shown that a mouse strain with a mutation that leads to dysfunction of mitochondria—the "powerhouses" that provide energy to cells—spontaneously undergo periodic ...

High-fat diet may cause changes in the brain that lead to anxiety and depression

October 19, 2015
A new study in mice reveals that increased body weight and high blood sugar as a result of consuming a high-fat diet may cause anxiety and depressive symptoms and measurable changes in the brain.

Scientists discover how to better map brain tumors

November 3, 2015
Scientists have discovered a protein that helps map the edge of brain tumours more clearly so they show up on magnetic resonance imaging (MRI) scans, according to new research presented at the National Cancer Research Institute ...

Recommended for you

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers

December 17, 2018
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of solid tumors many years later. In addition, certain subgroups of patients have an especially ...

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.